TRU Dental Implant System

K150968 · Sterngold Dental, LLC · DZE · Jul 24, 2015 · Dental

Device Facts

Record IDK150968
Device NameTRU Dental Implant System
ApplicantSterngold Dental, LLC
Product CodeDZE · Dental
Decision DateJul 24, 2015
DecisionSESE
Submission TypeAbbreviated
Regulation21 CFR 872.3640
Device ClassClass 2
AttributesTherapeutic

Intended Use

The TRU Implant System can be used in dental implant applications for oral rehabilitation of edentulous and partially dentate patients in the maxilla and mandible. Implant retained restorations may consist of single crowns or bridges as well as complete or partial dentures. The TRU Implant System is intended for delayed loading. It is also indicated for immediate loading with good primary stability and appropriate occlusal loading. The TRU Implant System is only intended for use with straight abutments. The TRU implant body is intended to be placed such no angle correction is necessary.

Device Story

TRU Dental Implant System consists of self-tapping, double-thread, root-form screw implants; manufactured from Grade 4 titanium with acid-etched surface. Available in various diameters (3.5-6.0mm) and lengths. Used by dentists/oral surgeons in clinical settings for oral rehabilitation. Implants placed in maxilla or mandible to support prosthetic restorations (crowns, bridges, dentures). System includes healing, straight, and UCLA abutments. Special driver facilitates insertion without implant mount. Device provides stable foundation for dental prosthetics; benefits patients by restoring chewing function and aesthetics. No angle correction permitted; intended for straight abutment use only.

Clinical Evidence

Bench testing only. Performance testing conducted per FDA guidance for root-form endosseous dental implants. Sterility, shelf life, and biocompatibility data leveraged from previously cleared Sterngold devices. Fatigue testing deemed unnecessary due to similarity to predicates and restriction to straight abutments without angle correction.

Technological Characteristics

Self-tapping, threaded, root-form endosseous dental implant. Material: Grade 4 titanium. Surface: Aluminum oxide blasted and acid-etched. Connection: Internal. Dimensions: 3.5mm-6.0mm diameter; 8mm-14mm length. Supplied sterile. Intended for straight abutments only; no angle correction.

Indications for Use

Indicated for oral rehabilitation of edentulous and partially dentate patients in the maxilla and mandible requiring single crowns, bridges, or complete/partial dentures. Suitable for delayed or immediate loading given good primary stability.

Regulatory Classification

Identification

An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.

Special Controls

*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features the department's name in a circular arrangement around a stylized symbol. The symbol consists of three abstract human profiles facing to the right, stacked on top of each other. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 July 24,2015 Sterngold Dental, LLC Maria Rao Director of QA & Regulatory Affairs 23 Frank Mossberg Drive Attleboro, Massachusetts 02703 Re: K150968 Trade/Device Name: TRU Dental Implant System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE, NHA Dated: June 26, 2015 Received: June 30, 2015 #### Dear Ms. Rao: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply {1}------------------------------------------------ with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, Susan Runno, DDS, MA Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ 510(k) Number (if known): _K150968 Device Name: TRU Dental Implant System ## Indications for Use: The TRU Implant System can be used in dental implant applications for oral rehabilitation of edentulous and partially dentate patients in the maxilla and mandible. Implant retained restorations may consist of single crowns or bridges as well as complete or partial dentures. The TRU Implant System is intended for delayed loading. It is also indicated for immediate loading with good primary stability and appropriate occlusal loading. The TRU Implant System is only intended for use with straight abutments. The TRU implant body is intended to be placed such no angle correction is necessary. # (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR Over-the -Counter Use (21 CFR 807 Subpart D) {3}------------------------------------------------ #### K150968 510(k) Summary | Trade Name: | TRU Dental Implant System | |----------------------|-------------------------------------------------------------------------| | Sponsor: | Sterngold Dental, LLC<br>23 Frank Mossberg Drive<br>Attleboro, MA 02703 | | | Contact: Maria Rao, QA/RA Director<br>Ph: 508-226-5660 ext 1206 | | Date: | July 23, 2015 | | Device Generic Name: | Endosseous Dental Implant | Classification: According to Section 513 of the Federal Food, Drug, and Cosmetic Act, the device classification is Class II Product Code: DZE (21CFR 872.3640) NHA (21CFR 872.3630) #### Predicate Devices: The TRU Dental Implant System is substantially equivalent to other currently marketed dental implant systems that have been cleared by FDA through the 510(k) Premarket Notification process, including the Sterngold Acid Etch Dental Implant System, and Nobel Active Internal Connection Implant System. ## Product Description: The TRU is a self-tapping, double thread screw implant with a micro groove section, manufactured from pure grade 4 titanium. The implant surface is acid etched. The implants are manufactured with four body diameters 3.5 mm, 4.3 mm, 5.0 mm, and 6.0 mm. The 3.5 mm implants have a Narrow Platform (NP) prosthetic head. The 4.3 mm, 5.0 mm, and the 6.0 mm implants have a Regular Platform (RP) prosthetic head. They provide for non-rotational single and multiple tooth restorations in both the maxilla and mandible. They are packaged sterile in a double blister, which contains the implant in a titanium tube. A special driver is available for the implants which simplant insertion by eliminating the need for an implant mount. The proposed TRU Dental Implant will be available in a range of lengths and diameters. | Thread Major Diameter (mm) | Overall Implant Length (mm) | |----------------------------|-----------------------------| | 3.5mm | 8mm 10mm, 12mm, 14mm | | 4.3mm | 8mm 10mm, 12mm, 14mm | | 5.0mm | 8mm 10mm, 12mm | | 6.0mm | 8mm, 10mm | The prosthetic components for the TRU implant System include Healing abutments, Straight Abutments and UCLA Abutments. {4}------------------------------------------------ Healing Abutments are intended for placement onto the implant. As the tissue heals, it conforms to the contours of the abutment. As the gingiva heals, the tissue adapts to the form of the healing abutment, creating permanent oral access to the implant and prepares the gingiva for the restorative phase. Straight Abutments attach directly to the implant and provide the transitional link between the head of the implant and the restorative components. They are designed to be used for screw retained multiimplant prostheses. They are available in a narrow platform with 1.5mm and a 3.0mm cuff size and in a regular platform with 1.5mm and a 3.0mm cuff size. UCLA Abutments attach directly to the implant and provide a pattern for the creation of a screw retained veneered crown. They are available with two apical (bottom) ends; one with a hex to engage the hex of the implant and one without a hex that does not engage the implant. The engaging/hexed abutment is used on restoration of a single tooth to prevent rotation of the completed crown, and the non-engaging/non-hexed is used on multiple tooth restorations. ## Indications for Use: The TRU Implant System can be used in dental implant applications for oral rehabilitation of edentulous and partially dentate patients in the maxilla and mandible. Implant retained restorations may consist of single crowns or bridges as well as complete or partial dentures. The TRU Implant System is intended for delayed loading. It is also indicated for immediate loading with good primary stability and appropriate occlusal loading. The TRU Implant System is only intended for use with straight abutments. The TRU implant body is intended to be placed such no angle correction is necessary. ## Substantial Equivalence: The proposed TRU Dental implants are substantially equivalent to other currently marketed dental implant systems that have been cleared by FDA through the 510(k) Premarket Notification process. The Indications for Use, basic design, fundamental operating principles are the same or similar as the predicate devices. - . Nobel Active Internal Connection Implant (K071370) - Primary Predicate - Sterngold Acid Etch Dental Implant System (K023580) Reference Predicate ● Compatibility and substantial equivalency was determined by comparing the design features including diameters, lengths, cuff sizes, materials, implant-to-abutment connection platform, implant surface texture, abutment fixation method, and intended use of proposed device to predicate devices. Any differences between the proposed devices and predicate devices do not render the device NSE. {5}------------------------------------------------ ## Technological Characteristics: The TRU dental Implant provides the same or similar functions as well as design and technological characteristics as the predicate devices. In addition the surface treatment is identical to the cleared Sterngold Acid Etched Implant (K023580). The materials, technology and processes used to produce the TRU dental implants and abutments are the same as other Sterngold Dental devices previously cleared by the FDA. See Substantial Equivalence Comparison table below. | Property | TRU Dental<br>Implant System<br>(Proposed Device) | Nobel Active Internal Connection Implant<br>(K071370)<br>Primary Predicate | Sterngold Acid Etch Dental<br>Implant System<br>(K023580)<br>Reference Predicate | |---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Implant<br>Design | Self-tapping, threaded, Root-form<br>implant | Self-tapping, threaded, Root-form implant | Self-tapping, threaded, Root-<br>form implant | | Implant Sizes<br>diameter x<br>length | 3.5x8mm,10mm,12mm,14mm<br>4.3x8mm,10mm,12mm,14mm<br>5.0mmx8mm,10mm,12mm<br>6.0mmx8mm,10mm,12mm | 3.5x8.5mm,10mm,11.5mm,13mm,15mm<br>4.3x8.5mm,10mm,11.5mm,13mm,15mm | 3.3x10mm,11.5mm,13mm<br>4.0x8.5mm,10mm,11.5mm,13mm,15mm<br>5.0x8.5mm,10mm | | Abutment<br>Compatibility | Internal Connection | Internal Connection | External Connection | | Implant Stage | Stage 1 and Stage 2 | Stage 1 and Stage 2 | Stage 1 and Stage 2 | | Placement<br>Accessories | Implant drills, countersinks, bone taps | Implant drills, countersinks, bone taps | Implant drills, countersinks,<br>bone taps | | Supplied<br>Sterile | Yes | Yes | Yes | | Intended Use | Implant applications for oral<br>rehabilitation of edentulous and<br>partially dentate patients in the maxilla<br>and mandible. Implant retained<br>restorations may consist of single<br>crowns or bridges as well as complete<br>or partial dentures. | Long term surgical implantation in the bone of<br>the patient's upper or lower arch to provide<br>immediate load or delayed load of prosthetic<br>systems, such as artificial teeth, in order to<br>restore the patient's chewing function. Also<br>indicated for for immediate loading with good<br>primary stability and appropriate occlusal<br>loading. | Implantation into any area of<br>the partially and/or fully<br>edentulous maxilla and<br>mandible for the support of a<br>removable or fixed dental<br>prosthesis. Intended for single<br>tooth or multiple unit<br>prosthesis. | | Implant<br>Material | Wrought Titanium 6AL-4V ELI | CP Titanium titanium grade 4 | CP Titanium titanium grade 4 | | Implant<br>Surface | Blasted with aluminum oxide particles<br>and acid etched | Blasted with aluminum oxide particles and acid<br>etched | Blasted with aluminum oxide<br>particles and acid etched | {6}------------------------------------------------ ### Performance Testing: Non clinical Testing was performed following "Guidance for Industry and FDA Staff -Class 11 Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Abutments." Performance testing demonstrated that the device performs appropriately for the proposed indications for use. Fatigue testing is not required because design features and technological features are similar to predicate devices; the implant body is not intended to be placed with any angle correction, and this submission does not contain any abutments for angle correction. Proposed devices have the same sterilization process and radiation dose, same shelf life and biocompatibility as previous cleared Sterngold devices, therefore sterility, shelf life and bio-compatibility testing performed on previous cleared Sterngold devices is applicable to the proposed new devices. As a result, the TRU Dental Implant System including abutments is substantial equivalent to the predicates. #### Conclusion: Based on the above analysis, technological characteristics and performance testing, the subject device is substantially equivalent in intended use, material, design and performance to its predicates.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%